An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers

PHASE4CompletedINTERVENTIONAL
Enrollment

1,041

Participants

Timeline

Start Date

October 5, 2016

Primary Completion Date

May 13, 2022

Study Completion Date

May 13, 2022

Conditions
Lung Cancer
Interventions
DRUG

Nivolumab in combination with Ipilimumab

Specified dose on specified days

Trial Locations (136)

1083

Local Institution - 0014, Budapest

1199

Local Institution - 0007, CABA

1426

Local Institution - 0008, Capital Federal

3233

Local Institution - 0013, Gyöngyös - Mátraháza

4000

Local Institution - 0126, San Miguel de Tucumán

Local Institution - 0037, Liège

4031

Local Institution - 0048, Basel

5000

Local Institution - 0009, Córdoba

8091

Local Institution - 0046, Zurich

8500

Local Institution - 0006, Viedma

9000

Local Institution - 0038, Ghent

9100

Local Institution - 0036, Sint-Niklaas

10461

Local Institution - 0167, The Bronx

11527

Local Institution - 0030, Athens

13915

Local Institution - 0069, Marseille

15006

Local Institution - 0061, A Coruña

15224

Allegheny Health Network, Pittsburgh

15232

Local Institution - 0159, Pittsburgh

16132

Ospedale Policlinico San Martino, Genova

18103

Local Institution - 0139, Allentown

18547

Local Institution - 0031, N. Faliro

18840

Local Institution - 0001, Sayre

20141

Local Institution - 0054, Milan

21044

Local Institution - 0091, Columbia

21079

Local Institution - 0075, Dijon

22031

Local Institution - 0097, Fairfax

23007

Local Institution - 0062, Jaén

23230

Local Institution - 0044, Richmond

27157

Local Institution - 0012, Winston-Salem

27710

Local Institution - 0004, Durham

28041

Local Institution - 0065, Madrid

28222

Local Institution - 0064, Majadahonda - Madrid

29414

Local Institution - 0123, Charleston

30322

Local Institution - 0002, Atlanta

30342

Local Institution - 0166, Atlanta

30607

Local Institution - 0163, Athens

32207

Cancer Specialists of North FL, Jacksonville

33028

Local Institution - 0147, Pembroke Pines

33076

Local Institution - 0118, Bordeaux

33604

Local Institution - 0074, Pessac

34125

Local Institution - 0029, Kassel

34474

Local Institution - 0082, Ocala

35033

Local Institution - 0071, Rennes

35205

Local Institution - 0121, Birmingham

37203

Local Institution - 0067, Nashville

37404

Local Institution - 0066, Chattanooga

39202

Jackson Oncology Associates, Pllc, Jackson

40509

Kentucky One Health St. Joseph East Cancer Center, Lexington

41013

Local Institution - 0063, Seville

44109

Local Institution - 0134, Cleveland

44805

Local Institution - 0070, Saint-Herblain

45242

Local Institution - 0100, Cincinnati

46026

Local Institution - 0059, Valencia

47014

IRST Meldola, Meldola

47923

Ospedale Degli Infermi, Rimini

50009

Local Institution - 0112, Zaragoza

53100

Azienda Ospedaliera Universitaria Senese, Siena

56429

Local Institution - 0032, Thessaloniki

60488

Local Institution - 0023, Frankfurt

60714

Local Institution - 0088, Niles

64060

Local Institution - 0019, Monterrey, NL

65199

Local Institution - 0025, Wiesbaden

67091

Local Institution - 0072, Strasbourg

67214

Local Institution - 0108, Wichita

68803

Local Institution - 0077, Grand Island

72205

Local Institution - 0164, Little Rock

74245

Local Institution - 0026, Löwenstein

75018

Local Institution - 0076, Paris

75230

Texas Oncology, P.A., Dallas

75231

Local Institution - 0149, Dallas

75601

Local Institution - 0093, Longview

76104

Local Institution - 0094, Fort Worth

76712

Local Institution - 0086, Waco

78745

Local Institution - 0090, Austin

80131

AOU della Campania Luigi Vanvitelli, Napoli

Local Institution, Napoli

80218

Local Institution - 0083, Denver

81501

Local Institution - 0141, Grand Junction

83056

Local Institution - 0073, Toulon

85016

Local Institution - 0148, Phoenix

85704

Local Institution - 0085, Tucson

89148

Local Institution - 0087, Las Vegas

89511

Local Institution - 0170, Reno

90017

Los Angeles Hematology/Oncology Medical Group, Los Angeles

90095

Local Institution - 0115, Los Angeles

90277

Torrance Health Association, Redondo Beach

90603

Local Institution - 0161, Whittier

92161

Va San Diego Healthcare System, San Diego

93309

Local Institution - 0146, Bakersfield

93401

Local Institution - 0143, San Luis Obispo

93454

Local Institution - 0144, Santa Maria

94904

Marin Cancer Care, Inc, Greenbrae

96161

Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee

97239

Local Institution - 0176, Portland

97330

Local Institution - 0172, Corvallis

97401

Local Institution - 0096, Eugene

98055

Local Institution - 0174, Renton

98201

Providence Regional Cancer Partnership, Everett

99208

Local Institution - 0173, Spokane

115478

Local Institution - 0022, Moscow

121309

Local Institution - 0021, Moscow

198255

Local Institution - 0020, Saint Petersburg

200347

Local Institution - 0119, Craiova

400015

Local Institution - 0120, Romania

8420383

Local Institution - 0010, Santiago

90610000

Local Institution - 0154, Porto Alegre

55435-2150

Local Institution - 0089, Edina

07109

Local Institution - 0156, Belleville

07932

Summit Medical Group, Florham Park

07039

Local Institution - 0142, Livingston

75075-7787

Local Institution - 0098, Plano

98700-000

Local Institution - 0152, Ijuí

91350-200

Local Institution - 0153, Porto Alegre

14780-070

Local Institution - 0151, Barretos

J4V 2H1

Local Institution - 0127, Greenfield Park

H4J 1C5

Local Institution - 0109, Montreal

G5L 5T1

Local Institution - 0049, Rimouski

G8Z 3R9

Local Institution - 0050, Trois-Rivières

Unknown

Local Institution - 0011, Santiago

741 01

Local Institution - 0133, Nový Jičín

128 08

Local Institution - 0130, Prague

07548

Local Institution - 0028, Gera

05100

Azienda Ospedaliera Santa Maria Terni, Terni

9714 CZ

Local Institution - 0045, Groningen

3014 GD

Local Institution - 0035, Rotterdam

85-796

Local Institution - 0015, Bydgoszcz

34-200

Local Institution - 0068, Sucha Beskidzka

02-781

Local Institution - 0016, Warsaw

021389

Local Institution - 0128, Bucharest

08035

Local Institution - 0060, Barcelona

07070

Local Institution - 0104, Antalya

SE1 9RT

Local Institution - 0041, London

LE1 5WW

Local Institution - 0039, Leicester

EH4 2XU

Local Institution - 0040, Edinburgh

CH63 4JY

Local Institution - 0042, Metropolitan Borough of Wirral

NE7 7DN

Local Institution - 0043, Newcastle upon Tyne

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT02869789 - An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers | Biotech Hunter | Biotech Hunter